Vir Biotechnology Inc (VIR)
7.96
-0.29
(-3.52%)
USD |
NASDAQ |
Apr 18, 16:00
7.96
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Total Liabilities (Quarterly): 328.82M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 328.82M |
| September 30, 2023 | 369.81M |
| June 30, 2023 | 433.67M |
| March 31, 2023 | 695.14M |
| December 31, 2022 | 724.12M |
| September 30, 2022 | 546.12M |
| June 30, 2022 | 666.98M |
| March 31, 2022 | 886.12M |
| December 31, 2021 | 522.42M |
| September 30, 2021 | 333.94M |
| Date | Value |
|---|---|
| June 30, 2021 | 320.26M |
| March 31, 2021 | 484.63M |
| December 31, 2020 | 201.91M |
| September 30, 2020 | 130.90M |
| June 30, 2020 | 108.46M |
| March 31, 2020 | 96.78M |
| December 31, 2019 | 88.13M |
| September 30, 2019 | 703.44M |
| June 30, 2019 | 55.40M |
| December 31, 2018 | 370.77M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
55.40M
Minimum
Jun 2019
886.12M
Maximum
Mar 2022
405.11M
Average
369.81M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 5.150B |
| Vistagen Therapeutics Inc | 7.783M |
| Immuneering Corp | 12.01M |
| SeaStar Medical Holding Corp | 17.38M |
| NovaBay Pharmaceuticals Inc | 5.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.919B |
| Shareholders Equity (Quarterly) | 1.590B |
| Current Ratio | 9.054 |